Mepolizumab Improves Exacerbation Outcomes in Patients with COPD with Type 2 Inflammation and Variable Eosinophil Patterns
Fields of Study & Subjects
Chronic Obstructive Pulmonary Disease (COPD) Research
Asthma and respiratory diseases
Cystic Fibrosis Research Advances
Publication details
- Journal / source
- Journal of Allergy and Clinical Immunology
- Volume
- 157
- Issue
- 2
- Pages
- AB412–AB412
- Publication date
- 1 February 2026
- Language
- EN